How to measure quality of life for cost-effectiveness analyses of personality disorders: A systematic review

Journal of Personality Disorders

Volumn 27, Issue 3, 2013, Pages 383-401

  Papaioannou, Diana ^a   Brazier, John ^a   Parry, Glenys ^a   Psychol, C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; ECONOMICS; HEALTH STATUS INDICATOR; HUMAN; PERSONALITY DISORDER; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; REVIEW; PSYCHOLOGY;

COST-BENEFIT ANALYSIS; HEALTH STATUS INDICATORS; HUMANS; PERSONALITY DISORDERS; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 84879138719     PISSN: 0885579X     EISSN: 19432763     Source Type: Journal    
DOI: 10.1521/pedi_2013_27_075     Document Type: Article

References (55)

1. Abbass, A., Sheldon, A., Gyra, J., & Kalpin, A. (2008). Intensive short-term dynamic psychotherapy for DSM-IV personality disorders: A randomized controlled trial. Journal of Nervous and Mental Disease, 196(3), 211-216.
2. Bartak, A., Andrea, H., Spreeuwenberg, M. D., Thunnissen, M., Ziegler, U. M., Dekker, J., et al. (2011). Patients with cluster A personality disorders in psychotherapy: An effectiveness study. Psychotherapy and Psychosomatics, 80(2), 88-99.
3. Bartak, A., Andrea, H., Spreeuwenberg, M. D., Ziegler, U. M., Dekker, J., Rossum B. V., et al. (2011). Effectiveness of outpatient, day hospital, and inpatient psychotherapeutic treatment for patients with cluster B personality disorders. Psychotherapy and Psychosomatics, 80(1), 28-38.
4. Bartak, A., Soeteman, D. I., Verheul, R., & Busschbach, J. J. V. (2007). Strengthening the status of psychotherapy for personality disorders: An integrated perspective on effects and costs. Canadian Journal of Psychiatry, 52(12), 803-810.
5. Bartak, A., Spreeuwenberg, M. D., Andrea, H., Holleman, L., Rijnierse, P., Rossum, B. V., et al. (2010). Effectiveness of different modalities of psychotherapeutic treatment for patients with cluster C personality disorders: Results of a large prospective multicentre study. Psychotherapy and Psycho- somatics, 79(1), 20-30.
6. Bateman, A. W., & Fonagy P. (2000) Effectiveness of psychotherapeutic treatment of personality disorder. British Journal of Psychiatry, 177, 138-143.
7. Berghout, C. C., Zevalkink, J., & Hakkaart- van, R. L. (2010). A cost-utility analysis of psychoanalysis versus psychoanalytic psychotherapy. International Journal of Technology Assessment in Health Care, 26(1), 3-10.
8. Binks, C. A., Fenton, M., McCarthy, L., Lee, T., Adams, C. E., & Duggan C. (2006). Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews, 2006(1).doi: 10.1002/14651858.CD005652.
9. Brazier, J. (2010). Is the EQ-5D fit for purpose in mental health? British Journal of Psychiatry, 197, 348-349.
10. Brazier, J., & Deverill M. (1999). A checklist for judging preference-based measures of health related quality of life: Learning from psychometrics. Health Economics, 8(1), 41-51.
11. Brazier, J., & Roberts J. (2004). Estimating a preference-based index from the SF- 12. Medical Care, 42(9), 851-859.
12. Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271-292.
13. Brazier, J., Rowen, D., Mavranezouli, I., Tsuchiya, A., Young, T., Yang Y., et al. (2012). Developing and testing methods for deriving preference-based measures of health from condition- specific measures (and other patient- based measures of outcome). Health Technology Assessment, 16(32), 1-114.
14. Brazier, J., Tumur, I., Holmes, M., Ferriter, M., Parry, G., Dent-Brown, K., et al. (2006). Psychological therapies including dialectical behaviour therapy for borderline personality disorder: A systematic review and preliminary economic evaluation. Health Technology Assessment, 10(35), 117.
15. Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37(1), 5372.
16. Cook, S., & Chambers, E. (2009). What helps and hinders people with psychotic conditions doing what they want in their daily lives. British Journal of Occupational Therapy, 72(6), 238-248.
17. Cramer, V., Torgerson, S., & Kringlen, E. (2006). Personality disorders and quality of life: A population study. Comprehensive Psychiatry, 47(3), 178-184.
18. Dolan, P. (1997). Modelling valuation for EuroQol health states. Medical Care, 35, 351-363.
19. European Medicines Agency. (2005). Preauthorisation evaluation of medicines for human use: Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. London, UK: EMEA. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2009/09/WC500003637.pdf
20. Gabbard, G. O. (2000). Psychotherapy of personality disorders. Journal of Psychotherapy Practice and Research, 9(1), 1-6.
21. Gabbard, G. O., Lazar, S. G., Hornberger, J., & Spiegel, D. (1997). The economic impact of psychotherapy: A review. American Journal of Psychiatry, 154(2), 147-155.
22. Hueston, W. J., Mainous, A. G., & Schilling, R. (1996). Patients with personality disorders: Functional status, health care utilization, and satisfaction with care. Journal of Family Practice, 42(1), 54-60.
23. Jackson, H. J., & Burgess, P. M. (2000) Personality disorders in the community: A report from the Australian National Survey of Mental Health and Wellbeing. Social Psychiatry & Psychiatric Epidemiology, 35(12), 531-538.
24. Jackson, H. J., & Burgess, P. M. (2002). Personality disorders in the community: Results from the Australian National Survey of Mental Health and Wellbeing Part II. Relationships between personality disorder, Axis I mental disorders and physical conditions with disability and health consultations. Social Psychiatry & Psychiatric Epidemiology, 37(6), 251-260.
25. Leichsenring, F., & Leibing, E. (2003). The effectiveness of psychodynamic therapy and cognitive behavior therapy in the treatment of personality disorders: A meta-analysis. American Journal of Psychiatry, 160(7), 1223-1232.
26. Marra, C. A., Rashidi, A. A., Guh, D., Kopec, J. A., Abrahamowicz, M., Esdaile, J. M., et al. (2005). Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Quality of Life Research, 14(5), 1333-1344.
27. Mayers, C.(2000). Quality of life: Priorities for people with enduring mental health problems. British Journal of Occupational Therapy, 63(12), 591-597.
28. McCrone, P., Patel, A., Knapp, M., Schene, A., Koeter, M., Amaddeo, F., et al. (2009). A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. Journal of Mental Health Policy and Economics, 12(1), 27-31.
29. Michalak, E. E., Kolesar, S., & Lam, R. W. (2006). Bipolar disorder and quality of life: A patient-centered perspective. Quality of Life Research, 15(1), 25-37.
30. Narud, K., & Dahl, A. A. (2002). Quality of life in personality and personality disorders. Current Opinion in Psychiatry, 15(2), 131-133.
31. Narud, K., Mykletun, A., & Dahl, A. A. (2005). Quality of life in patients with personality disorders seen at an ordinary psychiatric outpatient clinic. BMC Psychiatry, 5, article 10.
32. Ogrodniczuk, J. S., & Piper, W. E. (2001). Day treatment for personality disorders: A review of research findings. Harvard Review of Psychiatry, 9(3), 105-117.
33. Palmer, S., Davidson, K., Tyrer, P., Gumley, A., Tata, P., Norrie, J., et al. (2006). The cost-effectieveness of cognitive behavior therapy for borderline personality disorder: Results from the BOSCOT trial. Journal of Personality Disorders, 20(5), 466-481.
34. Papaioannou, D., Brazier J., & Parry, G. (2011). How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? (A systematic review). Value Hecdth, 14, 907-920.
35. Perry, J. C., Banon, E., & Ianni, F. (1999). Effectiveness of psychotherapy for personality disorders. American Journal of Psychiatry, 156(9), 1312-1321.
36. Perry, J. C., & Bond, M. (2000). Empirical studies of psychotherapy for personality disorder. In J. G. Gunderson & G. O. Gabbard (Eds.), Psychotherapy for personality disorders. Review of psychiatry (pp. 1-31). Washington, DC: American Psychiatric Publishing.
37. Persieus, K. I., Ekdahl, S., Zsberg, M., & Samuelsson, M. (2005). To tame a volcano: Patients with borderline personality disorder and their perceptions of suffering. Archives of Psychiatric Nursing, 19(4), 160-168.
38. Ranger, M., Tyrer, P., Miloseska, K., Fourie, G., Khaleel, I., North, B., et al. (2009). Cost-effectiveness of nidotherapy for comorbid personality disorder and severe mental illness: Randomized controlled trial. Epidemiologia e Psichiatria Sociale, 18(2), 128-136.
39. Räsänen, P., Roine, E., Sintonen, H., Semberg- Konttinen, V., Ryynänen, O., & Roine, R. (2006). Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. International Journal of Technology Assessment in Health Care, 22, 235-241.
40. Sainslow, C. A., & McGlashan, T. H. (1998). Treatment outcome of personality disorders. Canadian Journal of Psychiatry, 43(3), 237-250.
41. Sanderson, K., & Andrews, G. (2002). Prevalence and severity of mental health- related disability and relationship to diagnosis. Psychiatric Services, 53(1), 80-86.
42. Shea, M. T. (1993). Psychosocial treatment of personality disorders. Journal of Personality Disorders, 7, 167-180.
43. Soeteman, D. I., Timman, R., Trijsburg, R. W., Verheul, R., Busschbach, J. J. (2005). Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy. Psychiatric Services, 56(9), 1153-1155.
44. Soeteman, D. I., Verheul, R., & Busschbach, J. J. V. (2008). The burden of disease in personality disorders: Diagnosis- specific quality of life. Journal of Personality Disorders, 22(3), 259-268.
45. Soeteman, D. I., Verheul, R., Delimon, J., Meerman, A. M., van den Eijnden, E., Rossum, B. V., et al. (2010). Cost- effectiveness of psychotherapy for cluster B personality disorders. British Journal of Psychiatry, 196(5), 396-403.
46. Stevenson, J., & Meares, R. (1999). Psychotherapy with borderline patients: II. A preliminary cost benefit study. Australian and New Zealand Jouranl of Psychiatry, 33(4), 473-437.
47. Streiner, D. L., & Norman, G. R. (2003). Health measurement scales: A practical guide to their development and use (3rd ed.). New York: Oxford University Press.
48. Tolley, K.(2009). What are health utilities? Retrieved July 13, 2012, from http:// www.medicine.ox.ac.uk/bandolier/painres/download/whatis/Health-util.pdf
49. Tosh, J., Brazier, J., Evans, P., & Longworth, L. (2012). A review of generic preference-based measures of health-related quality of life in visual disorders. Value in Health, 15(1), 118-127.
50. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). (2009). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims. http:// www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf
51. van Asselt, A. D., Dirksen, C. D., Arntz, A., Giesen-Bloo, J. H., van Dyck, R., Spinhoven, P., et al. (2008). Out-patient psychotherapy for borderline personality disorder: Cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy. British Journal of Psychiatry, 192(6), 450-457.
52. van Asselt, A. D., Dirksen, C. D., Arntz, A., Giesen-Bloo, J. H., & Severens, J. L. (2009). The EQ-5D: A useful quality of life measure in borderline personality disorder? European Psychiatry, 24(2), 79-85.
53. Walters, S. J. (2009). Quality of life outcomes in clinical trials and health-care evaluation: A practical guide to analysis and interpretation. Chichester, UK: John Wiley.
54. Ware, J. E., Kosinski, M., & Keller, S. D. (1994). SF-36® physical and mental health summary scales: A user's manual. Boston, MA: The Health Institute.
55. Ware, J. E., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220-233.